Lung Therapeutics
UEI: R5Q5KNX9E9Z3
Overview
Awardee Type
Parent
(1 child)
Company Description
Lung Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapies for underserved, life-threatening lung conditions.
Name
Lung Therapeutics
Headquarters
Austin, TX
United States
United States
Most Recent Award
Sept. 15, 2023
Calculating
Federal grant recipient
LUNG THERAPEUTICS, INC
(UEI R5Q5KNX9E9Z3)
is headquartered in Austin TX.
The corporation
was founded in October 2012 and
federally registered in
March 2013.
Federal Award Analysis
Lung Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
This Parent entity does not have an associated active registration. Showing registration information for UEI KG3AMMKMEWE9 CAGE 6VDT5 instead.
Legal Name
LUNG THERAPEUTICS, INC
Division Name
AILERON THERAPEUTICS, INC
UEI
KG3AMMKMEWE9
CAGE Code
6VDT5
Primary NAICS
None Reported
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Assistance Awards
Date Founded
Oct. 1, 2012
Initial Registration
March 1, 2013
Last Registration
March 18, 2025
Registration Activation
March 20, 2024
Registration Expiration
March 18, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
TX
Country of Incorporation
USA
Employees
Not Available
Reported NAICS
None Reported
Accepts Credit Cards
No